Fortis Healthcare Limited has informed the Exchange about change in Management
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fortis Healthcare reported strong full-year FY2026 results with consolidated revenue from operations of Rs 91,278 lakhs, up 17% from Rs 77,828 lakhs in FY2025. Net profit grew 31% to Rs 10,642 lakhs from Rs 8,094 lakhs year-on-year. EBITDA stood at Rs 21,356 lakhs with operating profit margin of 23.11%. The board recommended a final dividend of Rs 1 per equity share (10% on Rs 10 face value) subject to shareholder approval. M/s Jitender, Navneet & Co. was appointed as Cost Auditor for FY2026-27. Statutory auditors B S R & Co. LLP issued an unmodified opinion, though they drew attention to ongoing SFIO investigation regarding alleged improper transactions from periods prior to 2018 takeover by the reconstituted board. Total assets as of March 31, 2026 were Rs 1,59,662 lakhs.
The results show healthy operational growth in both healthcare and diagnostics segments. The ongoing SFIO investigation remains a governance overhang though management has already made provisions for contingencies. Dividend payout provides direct return to shareholders.